The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.
CellDynamics addresses to a “More reliable biomedicine” and develops laboratory devices enabling a wider adoption of 3D Cell Models in the in vitro discovery and testing activity. We develop and build devices and add a strong biological competence.
Bologna, Emilia Romagna, Italy
Send a message
CellDynamics is glad to inform that 2021 started in the best way for its brand new product W8 Physical Cytometer. Despite the long tail of the pandemic and the very difficult procedures to organize demos on site with customers, CellDynamics closes at the end of June 2021 with 9 devices sold in Europe, China and Japan. More test activities are ongoing so that the company expects to continue in the future on this positive trend.
The hard work and activity developed from the end 2020 in order to promote and let users and customers know what is the disruptive proposal with W8 Physical Cytometer has been successful. All virtual solutions and activities done in distance developed have been able to reduce the barrier that traditionally was solved with demos on site.
Stay tuned on our web site and social pages to be informed on our future webinars and virtual activities in partnership with our early adopters.
Start in 2015 – Lab activity starts
2015 – Lab activity starts
CD locates inside CNR first Italian research institution, profits of access to laboratory and office
2015 - Grant RER
CD wins its first relevant grant from Region Emilia Romagna for its tech project 150k€
2015 - Seed 1
CD collects its first seed from F&F overall 200k€
2016 – First prototype
CD reaches a first working prototype for testing of single cells in floating conditions
to be continued ...